Research and treatment progress of thymoma
- VernacularTitle:胸腺瘤的研究及治疗进展
- Author:
Xin DU
1
;
Chao GUO
1
;
Cheng HUANG
1
;
Yeye CHEN
1
;
Ye ZHANG
1
;
Chao GAO
1
;
Xuehan GAO
1
;
Xiayao DIAO
1
;
Shanqing LI
1
Author Information
- Publication Type:Journal Article
- From: Chinese Journal of Thoracic and Cardiovascular Surgery 2025;41(1):42-48
- CountryChina
- Language:Chinese
- Abstract: Thymoma is a malignant tumor originating from thymus epithelial cells, with an incidence of 1.3-2.6 per million. Due to its low incidence, lack of cells and animal models, there are relatively few studies on thymoma, and its diagnosis and treatment progress is relatively slow. The update of 5th edition of WHO Classification of Thoracic Tumors in 2021 and the NCCN( National Comprehensive Cancer Network) Clinical Practice Guidelines in Oncology: Thymoma and Thymoma Cancer in 2024 put forward many new views and suggestions on the diagnosis and treatment strategy of thymoma. This article reviews the research and treatment of thymoma based on the latest research progress in recent years, aiming to improve the clinician's understanding of thymoma, provide reference for treatment, and promote the research of thymoma.
